| GOLDMAN SACHS GLOBAL FUTURE TECHNOLOGY LEADERS EQUITY PORTFOLIO R GBP DIS | RVI TECNOLOGÍA | 76,29% | 130,99% | 69,72% | · |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R CAP USD | RVI BIOTECNOLOGÍA | 76,26% | 75,06% | 84,06% | 246,44% |
| GOLDMAN SACHS GLOBAL FUTURE TECHNOLOGY LEADERS EQUITY PORTFOLIO R GBP CAP | RVI TECNOLOGÍA | 76,24% | 131,09% | 69,65% | · |
| ALLIANZ CHINA A OPPORTUNITIES AT USD | RVI CHINA | 76,23% | 59,70% | -7,70% | · |
| NORDEA 1-EMERGING EX CHINA SUSTAINABLE STARS EQUITY FUND BI-USD | RVI EMERGENTES | 76,23% | 114,03% | · | · |
| BGF NEXT GENERATION TECHNOLOGY A2 NZD (HEDGED) | RVI TECNOLOGÍA | 76,15% | 114,85% | · | · |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R CAP EUR | RVI BIOTECNOLOGÍA | 75,88% | 75,15% | 83,02% | 245,23% |
| POLEN CAPITAL U.S. SMALL COMPANY GROWTH FUND USD A RETAIL CAP | RVI USA SMALL/MID CAP | 75,85% | 67,49% | 21,95% | · |
| CARMIGNAC PORTFOLIO ASIA DISCOVERY A EUR ACC | RVI EMERGENTES | 75,84% | 122,56% | 93,88% | 173,11% |
| NORDEA 1-EMERGING EX CHINA SUSTAINABLE STARS EQUITY FUND BC-USD | RVI EMERGENTES | 75,84% | 112,69% | · | · |
